What Limerston Capital does

Limerston Capital is a UK mid-market private equity firm founded in 2015 by James Paget, João Rosa, and Martim Avillez. The firm pursues control investments in UK lower mid-market companies with EBITDA between £5 million and £15 million, targeting sectors including Healthcare & Life Sciences, Business & Financial Services, TICC (Testing, Inspection, Certification & Compliance), Leisure, Niche Industrials, and Education. Its stated differentiator is an operationally focused model in which an in-house team of operating partners works alongside portfolio company management from first meeting through exit, combined with a buy-and-build approach to create category leaders. The firm holds 12 platforms and has completed 41 cumulative bolt-on acquisitions.

The firm manages approximately £525 million in assets under management across two blind-pool funds, with Limerston Capital Partners II reaching a £245 million final close in March 2024. Limited partners span US, Asian, and European institutional investors including corporate pension plans, university endowments, charitable foundations, family offices, and fund managers. Limerston is authorised and regulated by the UK Financial Conduct Authority and operates from offices in London. Origination is driven by direct outreach, intermediary relationships, and operating-partner networks rather than broad-based marketing.

Revenue is generated primarily through private equity fund management fees on committed capital plus performance-related carry realized on exits. The firm has completed multiple realizations from Fund I, including the sales of Arch Sciences to Element (>30% IRR), Prism Healthcare to Charme Capital Partners (34% IRR), Village Bakery to Groupe Menissez (>3.5x MoM and 50% IRR), and elementsuite to Zellis Group. Recent strategic activity includes geographic expansion into the US (Cormica/TPM Laboratories) and Germany (Cormica/Zwisler Laboratorium), platform creation in biorepository services (Astoriom carve-out from Source BioScience), and entry into cyber security via the Xypher platform built through CyberCrowd, DigitalXRAID, and Aristi.

Name

Limerston Capital

Legal name

Limerston Capital LLP

Website

http://www.limerstoncap.com/

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

UK mid-market private equity firm Limerston Capital manages £525M AUM across two funds. Founded in 2015, it executes control buy-and-build investments in UK companies with EBITDA of £5M-£15M across healthcare, business services, TICC, and other sectors.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)

SIC

Investors, Nec (6799)

akta.pro primary industry

Small-Cap / Micro-Buyout (FSANABAD)

akta.pro secondary industries

Industry-Specialist Buyout (Sector-Focused) (FSANABAE), Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Private equity investments
• Buyout fund management
• Buy-and-build strategy
• Mid-market acquisitions
• Operational transformation

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Private Equity Fund Management: Limerston Capital generates returns through equity investments in portfolio companies, creating value through operational improvements, bolt-on acquisitions, and strategic repositioning, then realizing returns through exits to strategic buyers or other investors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Limerston Capital is a UK lower mid-market private equity firm that makes control investments in companies with EBITDA between £5 million and £15 million. The firm deploys capital alongside in-house operational expertise and executes buy-and-build strategies to create category leaders across Healthcare & Life Sciences, Business & Financial Services, TICC, Leisure, Niche Industrials, and Education sectors.

Product overview

Limerston Capital is a UK mid-market private equity investment firm, not a technology product company. The firm provides private equity investment services and does not offer a unified software product or platform. Its portfolio consists of investee companies across various sectors including healthcare, life sciences, business services, and cybersecurity. These portfolio companies operate independently and are not integrated under a common Limerston Capital product platform.

Differentiator

Problem solved

Functional benefit

Brands

• Limerston Capital Partners I: First fund vehicle of Limerston Capital focusing on UK mid-market investments
• Limerston Capital Partners II

Products and services

• Limerston Capital Partners I LP
• Limerston Capital Partners II

Quantifiable outcome

• Village Bakery exit delivered >3.5x MoM (Money on Money) and 50% IRR
• +4 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Ropes & Gray LLPsupportingImplementation/ SI/ Consulting PartnerRopes & Gray LLP served as legal adviser for Limerston Capital Partners II.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Others

• Graphite Capital:

Direct peers

• LDC (Lloyds Development Capital): UK lower mid-market PE firm investing across sectors with focus on management buyouts, growth capital and buy-and-build. Directly comparable in target company size, sector breadth, and UK mid-market focus.
• Bowmark Capital: UK lower mid-market PE firm targeting UK businesses with EBITDA typically between £5-£25M, executing buy-and-build strategies in Business Services, Healthcare, and Technology. Closely aligned with Limerston's size, strategy and sector mix.
• Inflexion Private Equity: UK mid-market PE firm executing buyouts and growth investments across Business Services, Healthcare and Consumer. Comparable size bracket and buy-and-build approach to UK lower mid-market opportunities.
• ECI Partners: UK mid-market PE firm investing in growth businesses across Business Services, Financial Services, TICC and Healthcare sectors with similar EBITDA target band. Directly comparable investment approach and sector overlap.
• Lyceum Capital: UK lower mid-market PE firm focused on growth buyouts and buy-and-build strategies in Business Services, Healthcare and Education. Highly comparable in fund size, target profile, and operational engagement model.
• Endless LLP: UK mid-market PE firm executing buyouts across diverse sectors with buy-and-build approach. Comparable in fund size, target EBITDA range and operationally-focused investment style.

Broad incumbents

• Bridgepoint Group: European mid-market PE firm with significant UK exposure and broad sector mandate. Larger fund size but overlapping target markets in lower mid-market and similar buy-and-build execution.
• Hg Capital: Large European PE/venture investor with UK focus on technology and services. Broader portfolio and larger fund size, but comparable in UK mid-market deal flow and sector overlap in business services and software.
• Oakley Capital: UK and European mid-market PE firm with focus on technology, business services and consumer brands. Larger fund vehicles but comparable buy-and-build approach in UK and European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/limerston-capital

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Limerston Capital